Page last updated: 2024-08-26

5,6-dihydro-5-azacytidine and Vomiting

5,6-dihydro-5-azacytidine has been researched along with Vomiting in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Creagan, ET; Hartmann, LC; Loprinzi, CL; Schaid, DJ1

Trials

1 trial(s) available for 5,6-dihydro-5-azacytidine and Vomiting

ArticleYear
A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma.
    American journal of clinical oncology, 1993, Volume: 16, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Biopsy; Chest Pain; Female; Humans; Immunologic Factors; Infusions, Intravenous; Male; Melanoma; Middle Aged; Nausea; Remission Induction; Risk Factors; Severity of Illness Index; Survival Rate; Vomiting

1993